Quantcast

Latest Oligonucleotide Stories

2010-04-09 08:30:00

BASKING RIDGE, N.J., April 9 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Steven Zelenkofske, DO, FACC, Senior Vice President, Chief Medical Officer, presented an abstract at the Arteriosclerosis, Thrombosis and Vascular Biology Scientific Sessions on April 9, 2010 at 5pm (PST) in San Francisco, CA. The poster, entitled "Subcutaneous RB006, a Direct FIXa Inhibitor Provides...

2010-04-09 07:00:00

SAN DIEGO, April 9 /PRNewswire/ -- TriLink BioTechnologies (TriLink), has entered into an agreement with Cedarlane Corporation, a Canadian based research biotechnology company, for the sale and distribution of its modified nucleoside triphosphates, custom chemistry and oligonucleotide products. TriLink CEO, Richard Hogrefe, Ph.D. commented, "We are pleased to partner with Cedarlane to enhance the distribution of TriLink's products in Canada and the Northern US. Our product line and values...

2010-03-15 08:30:00

BASKING RIDGE, N.J., March 15 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Chris Rusconi, PhD, Senior Vice President, Chief Scientific Officer and Steven Zelenkofske, DO, FACC, Senior Vice President , Chief Medical Officer presented an abstract at the American College of Cardiology on Monday, March 15, 2010 in Atlanta, Georgia. The poster, entitled "Subcutaneous FIXa...

2010-01-11 07:00:00

SAN DIEGO, Jan. 11 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink), a leading provider of custom nucleic acid-based compounds, announced it has signed a distribution agreement permitting tebu-bio SA (tebu) to sell its CleanAmp(TM) products. tebu-bio is a European based distributor that supplies over 750,000 reagents and lab services from manufacturers worldwide. TriLink's CleanAmp(TM) Product Line is an innovative new approach to Hot Start PCR. TriLink has applied their expertise...

2009-11-25 09:21:00

BASKING RIDGE, N.J., Nov. 25 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David Mazzo, PhD, CEO and President, will be presenting at the Piper Jaffray 21st Annual Health Care Conference at the New York Palace Hotel in New York City. Dr. Mazzo's presentation will be given at 1:10pm (EST) on Tuesday, December 1 and will include an overview of the Company's pipeline with emphasis on...

2009-11-12 08:36:00

BASKING RIDGE, N.J., Nov. 12 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David Mazzo, PhD, CEO and President, will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference at the St. Regis Hotel in New York City. Dr. Mazzo's presentation will be given at 1:10pm (EST) on Tuesday, November 17 and will include an overview of the Company's pipeline with emphasis on...

2009-11-11 08:00:00

BASKING RIDGE, N.J., Nov. 11 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Chris Rusconi, PhD, Senior Vice President and Chief Scientific Officer, will be presenting an abstract at Biotech 2009 held at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. Dr. Rusconi's abstract "Aptamer-Active Control Agent Pairs as a Discovery Platform for the Generation of Safer...

2009-11-10 08:00:00

BASKING RIDGE, N.J., Nov. 10 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at Biotech 2009 held at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. Ms. McDonald's presentation will be given at 10:15am (EST) on Monday, November 16 and will include an overview of...

2009-11-03 08:24:00

BASKING RIDGE, N.J., Nov. 3 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that David J. Mazzo, Ph.D., President and Chief Executive Officer, will be presenting at the 3rd Annual Canaccord Adams Cardiovascular Conference at the Nikko Hotel in San Francisco, California. Dr. Mazzo's presentation scheduled for Tuesday, November 10, 2009 at 1:30 PM (PST), will include an overview of the...

2009-11-03 07:00:00

ST. LOUIS, Nov. 3 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) today announced a worldwide licensing agreement with Polyplus-transfection (Strasbourg, France) to manufacture and commercialize Zip Nucleic Acid (ZNA(TM)*) oligonucleotides, a new technology that provides solutions for increased affinity for nucleic acids. Under the terms of the license, Sigma-Aldrich has rights to manufacture and commercialize ZNA oligonucleotides for all research applications. Sigma-Aldrich is...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related